Shockwave ®S4 Catheter IVL to Treat Infrapopliteal Calcified Stenoses and/or Occlusions in CLTI Patients (LEGACY)

Last updated: November 7, 2023
Sponsor: EndoCore Lab s.r.l.
Overall Status: Active - Recruiting

Phase

N/A

Condition

Peripheral Arterial Occlusive Disease

Claudication

Occlusions

Treatment

N/A

Clinical Study ID

NCT05755412
IVL012022
  • Ages > 18
  • All Genders

Study Summary

The study will evaluate the safety and efficacy of Peripheral Intravascular Lithotripsy system with Shockwave S4 catheter® for the treatment of de novo, re-stenosis or re-occlusive,calcified chronic total occlusion (CTOs) lesions in patients with Critical Limb Threatening Ischemia (CLTI).

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Age ≥18 years
  • Patient has signed an approved informed consent form
  • Patient with Critical Limb Ischaemia, Rutherford category 4 (ischaemic rest pain), 5(minor tissue loss) or 6 (major tissue loss)
  • Patient with Stenotic (>50% luminal loss) or occluded infrapopliteal artery, includingthe tibiofibular trunk, the anterior tibial artery, the posterior tibial artery andthe peroneal artery
  • The vascular lesion length will be no longer than 150 mm.
  • Patient with no significant disease at the inflow: common iliac, external iliac,superficial femoral and popliteal artery on the ipsilateral side prior to enrollment,and patient with no significant disease at the outflow - runoff to ankle level:plantar for posterior tibial, pedal for anterior tibial, anterior and posteriorperforant branches for peroneal vessels or previous successful revascularization ofthe disease segments (inflow-outflow)
  • Live expectancy > 1 year.
  • Presence at least ≥1 filling pedal vessel on the target limb.

Exclusion

Exclusion Criteria:

  • Subject pregnant or planning to become pregnant during the study
  • Subject no able to perform the follow up or other factors making clinical follow-updifficult
  • Acute or Subacute limb ischaemia which requires thrombolysis as first treatmentmodality or previous thrombolytic therapy in the last 48-72 hours.
  • Known allergy to concomitant medication, antiplatelet anti-coagulant or thrombolyticmedication
  • Poor inflow due to ipsilateral stenoses or occlusions of the iliac or femoropoplitealarteries
  • Significant stenoses (> 50%) distal to the target lesion that might requirerevascularization or impede run-off
  • Desert foot condition. No Patent foot main arteries
  • Subject enrolled in another investigational study that has not reached its primaryendpoint

Study Design

Total Participants: 32
Study Start date:
March 14, 2023
Estimated Completion Date:
March 31, 2025

Study Description

The present study is designed as a multicentre, prospective, single-arm, observational study.

All eligible subjects for undergoing intervention with Shockwave S4 catheter® Peripheral Intravascular Lithotripsy (IVL) at sites participating in the study will be considered for enrolment and will be asked to give consent prior to participating.

Subjects will be considered enrolled in the study at the time written informed consent is given to the use of their personal data. Once patients are enrolled, their demographics, medical history, disease-relevant conditions, treatment details and outcomes will be collected for up to 12 months from the procedure.

The study will collect information about the medical care patients receive during their planned procedure. No additional testing or procedures will be done.

The procedure with Shockwave S4 catheter® Peripheral Intravascular Lithotripsy (IVL) will be performed as per the current instructions for use.

After discharge all patients will attend clinic visits at 30 days (±14 days), 6 months (±30 days),12 months (±30 days).

Connect with a study center

  • I.R.C.C.S. MultiMedica

    Sesto San Giovanni, Milano 20099
    Italy

    Suspended

  • Casa di Cura Abano Terme

    Abano Terme, Padova 35031
    Italy

    Active - Recruiting

  • Ospedale Pederzoli

    Peschiera Del Garda, Veneto 37019
    Italy

    Active - Recruiting

  • Arcispedale Santa Maria Nuova

    Reggio Emilia, 42123
    Italy

    Suspended

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.